H up +1.60% percent right now. $H High is at 58.33 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
H up +1.60% percent right now. $H High is at 58.33 and the Low 57.38 with current volume of 92,123.

Recent News posted below.

H Hyatt Hotels Corp Recent Headline News

Hyatt Hotels Earnings Hindsight: Down 5.1% in Last 12 Days (H)
Comtex SmarTrend(R) - Mon Nov 10, 1:41PM CST
A week ago on October 29th, 2014 Hyatt Hotels (NYSE:H) reported earnings and analysts, on average, expected earnings of $0.26 on sales of $1.1 billion. Hyatt Hotels actually reported earnings of $0.20 per share on sales of $1.1 billion, missing EPS estimates by $0.06 and missing revenue estimates by $11.7 million. Since the company's report, shares of Hyatt Hotels have fallen from $60.60 to $57.53, representing a loss of 5.1% in the past 12 days.
H: 58.10 (+0.70)

Strong forecast for hotel industry
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:20AM CST

WYN: 79.04 (+1.37), HLT: 25.18 (+0.04), CHH: 53.61 (+0.94), HMIN: 30.70 (+0.30), EXPE: 86.37 (+0.37), MAR: 76.93 (+0.37), H: 58.10 (+0.70), IHG: 40.33 (+1.15), BEL: 11.18 (-0.06), STAY: 17.97 (-0.48), HOT: 77.69 (+0.90)

Hyatt's affiliate announces acquisition of remaining interest in Hyatt Regency Lost Pines Resort and Spa for USD143m
M2 - Mon Nov 10, 7:46AM CST
Hospitality company Hyatt Hotels Corporation (NYSE:H) revealed on Saturday that its affiliate has acquired its partners' 92% interest in the 491-room Hyatt Regency Lost Pines Resort and Spa in Austin/Bastrop, Texas, for about USD143m.
H: 58.10 (+0.70)

U.S. Hotel Outlook Makes Hyatt Hotels Worth Considering
Stock Gazer - at Seeking Alpha - Sat Nov 08, 9:32AM CST

H: 58.10 (+0.70)

Why Starwood Hotels Could Juice Your Portfolio
Main Street Wins - at Seeking Alpha - Fri Nov 07, 4:45PM CST

MAR: 76.93 (+0.37), H: 58.10 (+0.70), HOT: 77.69 (+0.90)

Hyatt Acquires Full Ownership of Hyatt Regency Lost Pines Resort and Spa
Business Wire - Fri Nov 07, 3:30PM CST
Hyatt Hotels Corporation (NYSE:H) today announced that a Hyatt affiliate has acquired its partners' 92 percent interest in the 491-room Hyatt Regency Lost Pines Resort and Spa in Austin/Bastrop, Texas, for approximately $143 million. The Company also assumed approximately $65 million of property-level debt. The total price, inclusive of debt, implies a valuation of approximately $450,000 per key. The transaction closed on November 6.
H: 58.10 (+0.70)

Access Point Financial Invited to Join the Center for Real Estate and Finance at the Cornell School of Hotel Administration
Business Wire - Thu Nov 06, 8:00AM CST
Access Point Financial (APF), a direct full-service lending and advisory firm focused on the hospitality industry, has been invited to join the strategic corporate alliance program at the Cornell School of Hotel Administration (SHA).
H: 58.10 (+0.70), HOT: 77.69 (+0.90)

Calling All Road Warriors: Hyatt Place Helps Travelers Stay Productive During Busy Travel Season
Business Wire - Wed Nov 05, 8:22AM CST
To kick-off the busy holiday travel season, millennial career expert and New York Times bestselling workplace author, Lindsey Pollak is serving as the new Hyatt Place Seamless Travel Series productivity expert to help travelers maintain productivity all the way into the new year. In addition to offering ongoing advice and her road warrior wisdom, Hyatt Place and Pollak have teamed up to curate a holiday go pack of tools to help guests make the most of their time on the road.
H: 58.10 (+0.70)

Hotels Gain from US Recovery: 2 Stock Picks - Analyst Blog
Swarup Gupta - Zacks Investment Research - Tue Nov 04, 10:59AM CST
In keeping with the rebound in the domestic economy, the U.S. hotel industry is making major gains.
HLT: 25.18 (+0.04), VAC: 71.84 (+0.60), H: 58.10 (+0.70), MAR: 76.93 (+0.37), STAY: 17.97 (-0.48), HOT: 77.69 (+0.90)

Hospitality Properties Trust Announces 2014 Third Quarter Results
Business Wire - Tue Nov 04, 7:01AM CST
--12.9% Growth in Comparable Property RevPAR for Hotels Not Under Renovation
MHGC: 8.04 (+0.02), WYN: 79.04 (+1.37), HPT: 29.98 (-0.29), H: 58.10 (+0.70), MAR: 76.93 (+0.37)

How You Can Profit Enormously With This Luxury Hotel Chain
Marcus Ho - at Seeking Alpha - Tue Nov 04, 4:49AM CST

H: 58.10 (+0.70)

Hyatt: A Pricey Upscale Hotel Chain
Time & Model - at Seeking Alpha - Mon Nov 03, 1:00PM CST

H: 58.10 (+0.70)

Hyatt Place Gurgaon/Udyog Vihar Opens in the Heart of Gurgaon
Business Wire - Mon Nov 03, 12:33PM CST
Hyatt Hotels Corporation (NYSE: H) and SAMHI today announced the opening of Hyatt Place Gurgaon/Udyog Vihar in the state of Haryana, India. This is the first Hyatt Place hotel in the gateway city of Delhi National Capital Region (NCR) and the second Hyatt Place hotel in India, following the 2012 opening of Hyatt Place Hampi.
H: 58.10 (+0.70)

Hilton Worldwide Beats Q3 Earnings & Revenues, Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:20AM CST
Hilton Worldwide Holdings Inc. (HLT) posted third-quarter 2014 results with both earnings and revenues beating the Zacks Consensus Estimate.
HLT: 25.18 (+0.04), H: 58.10 (+0.70), MAR: 76.93 (+0.37), HOT: 77.69 (+0.90)

U.S. Hotels In Sweet Spot As Ebola, Putin Weigh
at Investor's Business Daily - Fri Oct 31, 4:00PM CDT
Quarterly results trickling in from major hotels over the last week made clear the hospitality industry recovery that began a few years ago is -- at least in some regions -- stronger than ever. The U.S. hotel market is on a tear. But Ebola fears have...
WYN: 79.04 (+1.37), HLT: 25.18 (+0.04), CHH: 53.61 (+0.94), H: 58.10 (+0.70), MAR: 76.93 (+0.37), HTHT: 27.05 (+0.04), HOT: 77.69 (+0.90)

Wyndham Worldwide: Excellent Business, A Buyback Gondola No-Brainer
Time & Model - at Seeking Alpha - Fri Oct 31, 4:00AM CDT

WYN: 79.04 (+1.37), HLT: 25.18 (+0.04), CHH: 53.61 (+0.94), IILG: 23.65 (-0.05), H: 58.10 (+0.70), HOT: 77.69 (+0.90)

Hyatt (H) Q3 Earnings Miss, Revenues Beat on Solid RevPAR - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:42PM CDT
Hyatt Hotels Corporation (H) reported mixed third-quarter 2014 results, as earnings missed the Zacks Consensus Estimate, while revenues beat the same.
CHH: 53.61 (+0.94), H: 58.10 (+0.70), IHG: 40.33 (+1.15)

Hyatt misses on dips abroad
at Investor's Business Daily - Wed Oct 29, 5:32PM CDT
The int'l hotel chain's Q3 earnings fell 13% to 20 cents a share, missing views by 6 cents, as revenue rose 7.6% to $1.104 bil, just missing forecasts for $1.12 bil. Hyatt Hotels (H) revenue per available room rose 7.6%, year over year. Asia and...
H: 58.10 (+0.70)

Hyatt Hotels' (H) CEO Mark Hoplamazian on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 5:22PM CDT

H: 58.10 (+0.70)

First Hyatt Place Hotel Opens in Panama
Business Wire - Wed Oct 29, 3:23PM CDT
Hyatt Hotels Corporation (NYSE: H) and Immobiliare Real Estate Development Group today announced the opening of Hyatt Place Panama City/Downtown in Panama City, Panama. The hotel's opening marks the first Hyatt-branded hotel to enter the Panamanian market and the continued expansion of the Hyatt Place brand throughout Latin America.
H: 58.10 (+0.70)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading